Morphological and clinical results of invasive intra-arterial recanalization in the event of an acute stroke I Gubucz, Z Berentei, M Marosfői, C Óváry,

Slides:



Advertisements
Similar presentations
STROKE UPDATE Carlos S. Kase, M.D. Department of Neurology Boston Medical Center Medicine Grand Rounds New England Baptist Hospital March 17, 2011.
Advertisements

Endovascular treatment for Small Core and Anterior circulation Proximal occlusion with Emphasis on minimizing CT to recanalization times Michael D. Hill.
Beyond the Basics of Stroke Evaluation
The NINDS rt-PA Stroke Trial Prior information(Pre-Clinical, Phase I Studies, etc) Thrombolytic canalization of occluded arteries may reduce the degree.
Advanced Treatment Options for Stroke Patients Vickie Gordon PhD, ACNP-BC, CNRN.
Radial versus Femoral Randomized Investigation in ST Elevation Acute Coronary Syndrome the RIFLE STEACS study Enrico Romagnoli, MD PhD Principal investigators:
Anticoagulation in Acute Ischemic Stroke. TPA: Tissue Plasminogen Activator 1995: NINDS study of TPA administration Design: randomized, double blind placebo-controlled.
Established ischemic stroke: the role of lytics and surgery Michelle-Lee Jones September 1, 2010.
TOTAL Stroke in the TOTAL trial: Randomized trial of manual aspiration Thrombectomy in STEMI TOTAL Trial Investigators.
Intraarterial Thrombolysis
Journal Club Ani Balmanoukian and Peter Benjamin November 9, 2006 Journal Club Ani Balmanoukian and Peter Benjamin November 9, 2006.
Diagnostic and Therapeutic Options for Emergency Stroke Care: Perspectives from the US, Italy, and Developing Countries Andrew W. Asimos, MD Director of.
Interventional Stroke Treatment 2015
Endarterectomy versus Stenting in Patients with Symptomatic Severe Carotid Stenosis Dr. Quan, Dr. Mirhashemi, Dr. Chiang N Engl J Med 2006; 355:
Interventions in Acute Ischemic Stroke: Strategies for the New Millennium For the next 25 minutes, we will spend sometime talking about Neuroimaging.
Endovascular Therapy for Acute Ischemic Stroke ML006 Rev01.
What’s on the horizon? Peter Sandercock ESC Lisbon 23rd May 2012.
Thrombolysis in acute ischaemic stroke – Updated Cochrane Thrombolysis metaanalysis JM Wardlaw, V Murray, PAG Sandercock University of Edinburgh and Karolinska.
Tissue Plasminogen Activator for Acute Ischemic Stroke National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.
Evidence in the ED Byron Drumheller, MD Penn Emergency Medicine.
Overview of new acute stroke trials Shawna Cutting, MD, MS Rush University Medical Center June 9, 2015.
Intra - Arterial Thrombolysis for acute stroke
AIRE: Acute Infarction Ramipril Efficacy study Purpose To determine whether the ACE inhibitor ramipril reduces mortality in patients with evidence of heart.
The Acute Stroke Menu: Something off the Back Page Innovative ways to use IV t-pa and other assorted therapies available outside the standard treatment.
Simple CBF grading based on MR perfusion to anticipate long-term clinical outcome in severe stroke patients due to the carotid artery occlusion Mori T,
Safety and Efficacy of Intravenous Enoxaparin in Elective Percutaneous Coronary Intervention: an International Randomized Evaluation (STEEPLE) Presented.
Lone Star Stroke Consortium TeleStroke Registry (LESTER) Tzu-Ching (Teddy) Wu, MD Director of Telemedicine.
Long-term clinical outcome following emergency MR-based reperfusion therapy for acute middle cerebral artery occlusion Department of Stroke Treatment,
Thrombolysis: The Evidence Barry Moynihan Stroke Physician, St. George’s Hospital SITS/BASP Thrombolysis Nursing Training Day March 26 th 2012.
Intervention in Stroke- Intra-arterial thrombolyis and Mechanical thrombectomy Dr Sanjeev Nayak Consultant Neuroradiologist.
before thrombolysis in acute stroke
A multimodal step-up approach as rescue therapy of ischemic stroke L. Verganti, S. Vallone, C. Moratti, M. Malagoli, P. Carpeggiani Department of Neuroscience,
Long-Term Clinical Outcome After Emergency MR-based Reperfusion Therapy for Acute Basilar Artery Occlusion Department of Stroke Treatment, Shonan Kamakura.
Kim, Sun-Yong, M.D. Department of Radiology Ajou University Hospital, Suwon, Korea AGGRESIVE MECHANICAL CLOT DISRUPTION FOR ACUTE ISCHEMIC STROKE WITH.
The Potential of Stent-Trievers: Experience in 108 Acute Ischemic Stroke Treatments T. Liebig, H. Lockau, S. Stehle, D. Dorn, S. Prothmann, A. Foerschler,
MR CLEAN Multicenter Randomized CLinical Trial of Endovascular Treatment of Acute Ischemic Stroke in the Netherlands C.B. Majoie, Y.B. Roos, A. van der.
Time Is Brain: Advanced Stroke Treatment Grahame C Gould, MD Jefferson Neurosurgical Associates at Main Line Health, Bryn Mawr Hospital Division of Neurovascular.
ACUTE TREATMENT OF STROKE: RECENT ADVANCES AND PERFORMANCE AT CAMPBELLTOWN ALEX BUTTFIELD ED STAFF SPECIALIST.
Date of download: 5/31/2016 Copyright © The American College of Cardiology. All rights reserved. From: Mechanical Thrombectomy for Acute Ischemic Stroke:
Stent-assisted Mechanical Recanalization for Treatment of Acute Intracerebral Artery Occlusion C. Roth ‡, P. Papanagiotou ‡, S. C.
High-risk ST elevation MI patients (>4 mm elevation), Sx < 12 hrs 5 PCI centers (n=443) and 22 referring hospitals (n=1,129), transfer in < 3 hrs High-risk.
Abstract No: eEdE-103 Submission Number: Disclosure There is no disclosure.
O Mansour, J Weber and M Schumacher Neuroradiology Depart. Freiburg Univ. Neurology Depart. Alexandria Univ. Department of Neuroradiology, Neurocenter.
SPEED : GUSTO-IV PILOT GUSTO-IV Pilot Trial. SPEED : GUSTO-IV PILOT Rationale for Combination Therapy in AMI Enhance Incidence and Speed of Reperfusion.
Treating Acute Ischemic Stroke, Can We Open Up the Time Window?
Table 1: Table 2: Non Therapeutic Angiograms in Acute Ischemic Stroke Patients Being Considered for Endovascular Treatment Does not Adversely Affect Patient.
Direct catheter-based thrombectomy in acute ischemic stroke
Thrombectomy in Acute Stroke
Sameer A. Ansari, MD, PhD Associate Professor
Acute Stroke Therapy with IV Thrombolysis Lawrence R. Wechsler, M.D.
First Stroke Unit in Al Ain: Five Years Experience
Cardiovascular Research Technology Conference (CRT 17)
LONG-DES II Trial Randomized Comparison of the Efficacy of Sirolimus-Eluting Stent Versus Paclitaxel-Eluting Stent in the Treatment of Long Native Coronary.
Mechanical thrombectomy
PMA Analysis of the CREST Trial Approvability of the RX Acculink Carotid Stent System for Revascularization of Carotid Artery Stenosis in Standard Surgical.
Icahn School of Medicine Mount Sinai Hospital
Study Design AMI <12 hours, any age, cardiogenic shock excluded
Disclosures. Evaluating Recent Clinical Trial Data in the Secondary Prevention of ACS.
The Safety and Efficacy of Full vs
Modified Rankin score 0-2
Probability of No Urgent Repeated Percutaneous Revascularization Procedures in the Three Treatment Groups (Kaplan-Meier Plots) Figure 1. Probability of.
Published in the European Heart Journal
Randomized Comparison in the Setting of Acute MI
Extended Window Thrombectomy
Carotid Stenting in Acute Ischemic Stroke Resulting from Tandem Occlusions STEWART WEBER, MD.
Martin B. Leon, David R. Holmes, Dean J. Kereiakes, Jeffrey J
European Heart Journal Advance Access
OPTIDUAL Trial design: Patients who received a drug-eluting stent and were event-free at 12 months were randomized to an additional 36 months of DAPT with.
INTRO AMI. INTEGRILIN AND. REDUCED DOSE. OF THROMBOLYTIC IN. ACUTE
Update from education committee
Presentation transcript:

Morphological and clinical results of invasive intra-arterial recanalization in the event of an acute stroke I Gubucz, Z Berentei, M Marosfői, C Óváry, D Varga, N Szegedi, I Szikora National Neuroscience Institute, Budapest, Hungary

Background: Intravenous recanalization In case of major arterial occlusion Low recanalization rate: % High frequency of early reocclusion: 34% vs IAT17% Neurology 2002;59:862, AJNR 2004;25:322 Narrow therapeutic time window

Purpose To evaluate the morphological and clinical efficacy of intra-arterial recanalisation techniques furthermore the safety of the procedure Applied within a 6 hrs time window With or without iv therapy In a stroke center providing 24 hrs stroke service including intra-arterial procedures

Methods and materials: Patient selection ICA-TM1 BA major vessel occlusion within 6 hours time window

<3 (4.5) hours Major vessel occlusion IVT mg/kg rtPA successful unsuccessful 3 (4.5) -6 hours Major vessel occlusion IAT and/ MT Extended time window at basilar occlusion IAT and/ MT Extended time window at basilar occlusion Methods and materials: Therapeutic algorithm

Methods and materials: Endpoints Collateral flow Recanalization rate Early clinical outcome: ≥4 points improvement on NIHSS within 24 hrs Late clinical outcome: Mortality and functional outcome after 6 months Safety: Intracerebral bleeding and procedural complications

Pretreatment evaluation of DSA: Collateral flow R.T. Higashida, at al: Trial design and reporting standards for IA cerebral thrombolyis for acute ischemic stroke. Stroke. 2003;34:109

Posttreatment evaluation of DSA Recanalization (TICI) T. Tomsic, and the IMS-II investigators: Revascularization results in the International Management of Stroke II Trial. AJNR. 2008; 29(3):582

Classifaction of outcomes and safety Early outcome: 24 hrs ≥4 points improvement on NIHSS mRS=0-2: GOOD mRS=6: DEATH Bleeding Stroke, 2001; 32:1330 Procedural complications Safety HI-1 HI-2 PH-1PH-2 Late outcome: 6 months

Result: Patient cohort January 2007 – May 2010 Total: 77 patients 6-month follow up: 68 patients Retrospective, single arm study Initial NIHSS18.8 ± 5.2 (7-30) NIHSS after 24 hrs15.3 ± 8.3 (0-30) Treatment started3.9 ± 1.7 ( ) Treatment finished6.19 ± 1.5 ( )

Results: Treatment techniques Mean No of modalities/case 3.25± 1.55 (1-6) 1. IVT 50% 2. IAT 84% 3. MT 97% Thrombus fragmentation with balloon 15% with guide wire 82% Embolectomy Thrombectomy & Thrombaspiration 71% Stents 20%

Results ΔNIHSS≥4Recanalization6-month outcomeComlications 44%TICI0: 12%mRS≤2: 35%PH2: 11% TICI1: 10%mRS=3-5: 29% Procedural ̴ : 0 TICI2A: 25%Death: 36% TICI2B: 38% TICI3: 15% TICI2-3: 78%!

Deaths after Six months mortality: 25 pts (36%) Recanalization p=0.033 Collaterals p=0.001 ΔNIHSS≥4/24h p=0.000 Age (years) p=0.120 TICI0: 62.5%G0: 0%Yes: 4%17-50: 28% TICI1: 43%G1: 68%No: 96%51-74: 33% TICI2A: 53%G2: 31%≥75: 64% TICI2B: 31%G3: 11% TICI3: 0%G4:- Chi-square test

mRS≥2 after 6 months: 24 pts (35%) Recanalization p=0.001 Collaterals p=0.000 ΔNIHSS≥4/24h p=0.000 Age (years) p=0.082 TICI0: 12.5%G0: 50%Yes: 92%17-50: 55.5% TICI1: 0%G1: 4.5%No: 8%51-74: 31% TICI2A: 23%G2: 30.8%≥75: 18% TICI2B: 38.5%G3: 78% TICI3: 90%G4:- Chi-square test

Conclusion Both early and late outcomes are strongly related to: collateral flow AND recanalization rate At least TICI2B reperfusion in the affected area is needed for better outcome Only TICI2B-3 recanalization means SUCCESSFUL Clinacal Outcome